MAPS conference in Israel (Video)

Here are the available video segments and related powerpoint presentations:

MAPS conference in Israel. MAPS sponsored a one-day scientific conference in Israel, in conjunction with the Israeli Ministry of Health and the Society of Addiction Medicine, in support of the proposed MDMA/PTSD study. After the conference, the study’s primary investigator, Dr. Moshe Kotler, submitted the study protocol.

Speakers, in order of presentation, were:

  • Rick Doblin, Ph.D., MAPS President
  • Michael Mithoefer, M.D., primary investigator for the U.S. MAPS-sponsored MDMA/PTSD study
  • Raphael Mechoulam, Ph.D., Israeli cannabis researcher who discovered THC and the endocannabinoid system
  • Jose Carlos Bouso, Ph.D. Candidate, primary investigator for the proposed MAPS-sponsored MDMA/PTSD study in Spain
  • June May Ruse, Ph.D., director of the MDMA/PTSD Treatment Manual project
  • Valerie Mojeiko, MAPS Clinical Research Associate coordinating the outcome study on ibogaine for substance abuse
  • Udi Bastiaans, M.D., Israeli doctor researching ibogaine treatment
  • John Halpern, M.D., primary investigator for the MAPS-sponsored study of MDMA-assisted psychotherapy for anxiety in cancer patients, to be conducted at Harvard Medical School’s McLean Hospital
  • Jordi Riba, Ph.D., Spanish pharmacologist researching ayahuasca
  • Torsten Passie, M.D., German psilocybin researcher